Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER - CLINICAL DATA INC | b79386exv31w2.htm |
| EX-31.1 - EX-31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - CLINICAL DATA INC | b79386exv31w1.htm |
| 10-Q - CLINICAL DATA, INC. - CLINICAL DATA INC | b79386e10vq.htm |
EXHIBIT 32.1
STATEMENT PURSUANT TO 18 U.S.C. § 1350
In connection with the Quarterly Report on Form 10-Q of Clinical Data, Inc. (the “Company”)
for the period ended December 31, 2009 as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), the undersigned, Andrew J. Fromkin, Chief Executive Officer and
President of the Company, and C. Evan Ballantyne, Executive Vice President and Chief Financial
Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
| /s/ Andrew J. Fromkin | ||||
| Date: February 9, 2010 | Andrew J. Fromkin | |||
| President and Chief Executive Officer | ||||
| /s/ C. Evan Ballantyne | ||||
| Date: February 9, 2010 | C. Evan Ballantyne | |||
| Executive Vice President and Chief Financial Officer | ||||
This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the
Securities and Exchange Commission and is not incorporated by reference into any filing of the
Company under the Securities Exchange Act of 1933, as amended, or the Securities Exchange Act of
1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any
general incorporation language contained in such filing.